
    
      The study will start recruitment in April 2019.In this clinical trial, 50-100 females, aged
      50 to 90 years of age, with a diagnosis of thumb CMC OA, will be recruited. The primary
      outcome of potential risk factors of osteoarthritis, pain and function will be measured using
      the demographic data, visual analog scale (VAS) and Disabilities of the Arm, Shoulder and
      Hand (QuickDASH). Secondary out-comes will include the Pain Self-Efficacy Questionnaire
      (PSEQ), Tampa Scale of Kinesiophobia (TSK), Fear Avoidance Beliefs Questionnaire (FABQ),
      Hospital Anxiety and Depression Scale (HADS) and Impairment and Functioning Inventory (IFI).
      Measurements will be tak-en at the baseline, three, six and 12 months follow up.
    
  